// our company

Our Management Team

eTheRNA is managed by an experienced team of committed biotech professionals.
A team dedicated to bringing eTheRNA’s mRNA-based TriMix technology to the next level.

Steven Powell

CEO

Steven Powell

Steven has acquired broad experience in several life-science sectors in R&D, corporate finance and commercial roles. He started his career with Beecham Pharmaceuticals (now GSK) and subsequently held senior roles with both public and private biotechnology and healthcare companies in Europe and North America. He was also a partner with a European venture capital fund.

Bernard Sagaert

VP Manufacturing

Bernard Sagaert

Bernard is an industrial pharmacist and licensed Qualified Person with extensive and broad experience in the Pharmaceutical industry internationally in large, medium sized and small companies.

Diane Van Hoorick

VP Translational Development

Diane Van Hoorick

Diane is a molecular biophysicist with over 10 years of experience in pharmaceutical R&D; from drug discovery to clinical development. Before joining eTheRNA, Diane held the position of Head of immune oncology project management at Ablynx, Sanofi.

Dirk Van Broekhoven

VP Corporate Management, General Counsel

Dirk Van Broekhoven

Dirk has more than twenty-five years of experience as legal counsel in the healthcare industry. In addition to his general legal, he has specialized in intellectual property management and corporate development and licensing.

Marina Cools

VP Clinical Development

Marina Cools

Marina is a virologist with over twenty years of experience in pharmaceutical R&D; from drug discovery to late stage clinical development. She has worked with biotech SMEs and large pharmaceutical companies.

Michael Mulqueen

VP Business Development

Michael Mulqueen

Michael started his career with Roche as part of the business development department with a strong focus on in-licensing and alliance management. He left Roche to set up Synosia Therapeutics AG. From this point on, he worked with a number of European biotech companies with a focus on out-licensing and partnering. Latterly, he was VP for BD and Licensing with Silence Therapeutics in the RNAi field.

Stefaan De Koker

Stefaan De Koker

Stefaan is Principal Scientist with over 15 years of research experience in immunology, immuno-oncology, vaccine design and nucleic acid delivery. He has a publication track record of over >50 publications and is the key author of a number of patents.

Ulrich Platte

CFO

Ulrich Platte

Ulrich has over 20 years experience in a number of different industrial sectors including the life science, medical device and pharmaceutical sectors. He has held senior positions in financial management roles, including previous CFO roles.

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2020 Etherna | Studio Hanswijk